<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" 
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://www.openbell.ai/</loc>
    <lastmod>2026-09-22T16:45:12.757Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>1.0</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/support</loc>
    <lastmod>2026-09-22T16:45:12.757Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/privacy</loc>
    <lastmod>2026-09-22T16:45:12.757Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/terms</loc>
    <lastmod>2026-09-22T16:45:12.757Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/feed.json</loc>
    <lastmod>2026-09-22T16:45:12.757Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/PYPL:1790095508414</loc>
    <lastmod>2026-09-22T16:45:08.414Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PYPL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>PayPal Collaborates With Meta For Clients To Shop, Check Out Through Muse Personal AI Agents</image:title>
      <image:caption>PayPal has announced a collaboration with Meta to enable clients to shop and check out using Muse personal AI agents. This partnership aims to enhance the shopping experience by integrating AI technology into the payment process. Details regarding financial implications or specific terms of the collaboration were not disclosed.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/PLTR:1790094997230</loc>
    <lastmod>2026-09-22T16:36:37.230Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/22/New-York-City--New-York---September-3-20.jpg?width=250&amp;height=187</image:loc>
      <image:title>Palantir Golden Cross Brings This Key Level Into Focus</image:title>
      <image:caption>Palantir Technologies Inc (NASDAQ: PLTR) shares are currently trading at $183.81, up 0.40%, as they approach the upper end of a trading range between $166 and $188. The stock has shown a significant rally since early August, moving from around $125 to the mid-$160s, and recently crossed above its 50-day moving average, indicating a bullish trend. A decisive break above the $188 level could lead to a retest of its all-time closing high of $207.18 set on November 3 of last year.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/AAPL:1790094907499</loc>
    <lastmod>2026-09-22T16:35:07.499Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/22/Beijing--China---July-21--2023-Apple-Log.jpg?width=250&amp;height=187</image:loc>
      <image:title>Apple’s New Macs Are Faster, Smarter and Built for AI</image:title>
      <image:caption>Apple Inc. has launched new Mac models, including the Mac mini and Mac Studio, featuring advanced M6 and M5 Pro chips, which offer up to four times faster AI performance and 40% faster CPU performance. The Mac mini starts at $899, while the Mac Studio begins at $2,499. Apple stock rose about 1% to $342.31, nearing its 52-week high of $344.57, as analysts express optimism about iPhone demand and the upcoming Duo foldable device, despite concerns over the company&#39;s high valuation at approximately 33 times fiscal 2027 earnings.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/AMZN:1790094885704</loc>
    <lastmod>2026-09-22T16:34:45.704Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AMZN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Anthropic Introduces Claude Opus 5.5, Now Available On All Platforms, Including AWS, Google Cloud &amp;amp; Microsoft Azure; Claude Opus 5.5 Performs At Level Of Claude Fable 5.1 On Most Work, Costs Around 40% Less To Run Than Opus 5; Says Over Coming Weeks, We&amp;#39;ll Also Be Launching Claude Sonnet 5.5 &amp;amp; Haiku 5.5</image:title>
      <image:caption>Anthropic has launched Claude Opus 5.5, which is now available on major platforms including AWS, Google Cloud, and Microsoft Azure. The new model performs comparably to Claude Fable 5.1 while being approximately 40% cheaper to operate than its predecessor, Opus 5. The company also plans to introduce Claude Sonnet 5.5 and Haiku 5.5 in the upcoming weeks.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/AMZN:1790094683522</loc>
    <lastmod>2026-09-22T16:31:23.522Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AMZN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Amazon Web Services Now Available For Use By NATO Member Nations To Handle Restricted Workloads</image:title>
      <image:caption>Amazon Web Services (AWS) has been approved for use by NATO member nations to manage restricted workloads. This development marks AWS as the first cloud provider to offer such services to NATO, potentially enhancing the cloud capabilities of member nations. The partnership is expected to facilitate secure data handling and improve operational efficiency within NATO operations.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/BTCUSD:1790094467221</loc>
    <lastmod>2026-09-22T16:27:47.221Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/22/Los-Angeles--California---July-10-2025-B.jpg?width=250&amp;height=187</image:loc>
      <image:title>EXCLUSIVE: &amp;#39;Institutions Are Buying Bitcoin&amp;#39; — Retail Is Trading Everything Else</image:title>
      <image:caption>Institutional interest in Bitcoin is increasing, with U.S. spot Bitcoin ETF assets under management rising from approximately $79 billion to $102 billion as of September 10, marking a $23 billion increase. Bitcoin&#39;s market dominance remains near 59%, indicating that institutional investments are becoming more concentrated in Bitcoin rather than spreading across the broader crypto market. In contrast, retail investors are gravitating towards meme coins, AI tokens, and tokenized stocks, with meme coins having a market cap of about $28.8 billion and daily trading volume of $3.5 billion. This divergence suggests a growing two-track market in the cryptocurrency space.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/AAPL:1790094366815</loc>
    <lastmod>2026-09-22T16:26:06.815Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AAPL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>&amp;#39;Apple Is Developing New Fitness Tracker Aimed at Rivaling Whoop&amp;#39; - Bloomberg News</image:title>
      <image:caption>Apple is reportedly developing a new fitness tracker designed to compete with Whoop, a company known for its advanced health monitoring technology. This move indicates Apple&#39;s continued investment in the wearables market, aiming to enhance its product offerings in health and fitness. The development aligns with Apple&#39;s broader strategy to integrate health features into its ecosystem, potentially impacting its market position against competitors.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/QTWO:1790094344303</loc>
    <lastmod>2026-09-22T16:25:44.303Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/QTWO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Piper Sandler Reiterates Overweight on Q2 Holdings, Maintains $82 Price Target</image:title>
      <image:caption>Piper Sandler analyst Bill Carcache has reiterated an Overweight rating on Q2 Holdings (NYSE: QTWO) and maintained a price target of $82 for the stock. No additional financial figures or strategic changes were mentioned in the article.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/CLDX:1790094318010</loc>
    <lastmod>2026-09-22T16:25:18.010Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/22/Asian-Woman-Facial-Skin-With-Red-Spots-A.jpg?width=250&amp;height=187</image:loc>
      <image:title>Celldex Prepares For 2027 FDA Submission for Chronic Skin Disease</image:title>
      <image:caption>Celldex Therapeutics Inc. (NASDAQ: CLDX) announced positive topline results from its Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 clinical trials for barzolvolimab, aimed at treating chronic spontaneous urticaria (CSU). The trials met both primary and secondary endpoints, showing significant improvements in disease activity and a favorable safety profile. The company plans to submit a Biologics License Application to the FDA in 2027. Following the announcement, Celldex shares fell by 12.51% to $36.65.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/MU:1790094162731</loc>
    <lastmod>2026-09-22T16:22:42.731Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/22/Micron-Technology-Logo-Displayed-On-Sign.jpg?width=250&amp;height=187</image:loc>
      <image:title>What Is Going on With Micron Stock on Tuesday?</image:title>
      <image:caption>Micron Technology, Inc. (NASDAQ: MU) stock increased by over 6% on Tuesday, trading at $1,080.75, as investors prepared for its upcoming earnings report on September 30. Analysts anticipate quarterly revenue of $50.62 billion and adjusted earnings of $31.30 per share, driven by strong demand for AI memory. Additionally, Micron faces potential competition from China&#39;s CXMT, which has captured 9.5% of global DRAM revenue and is planning to develop NAND technology, although large-scale production remains uncertain.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/MSI:1790093891508</loc>
    <lastmod>2026-09-22T16:18:11.508Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MSI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Piper Sandler Maintains Overweight on Motorola Solutions, Raises Price Target to $531</image:title>
      <image:caption>Piper Sandler analyst James Fish has maintained an Overweight rating on Motorola Solutions (NYSE: MSI) and increased the price target from $530 to $531. This adjustment reflects confidence in the company&#39;s performance and potential for growth.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/PHAR:1790093768181</loc>
    <lastmod>2026-09-22T16:16:08.181Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PHAR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>HC Wainwright &amp;amp; Co. Reiterates Buy on Pharming, Maintains $37 Price Target</image:title>
      <image:caption>HC Wainwright &amp; Co. analyst Joseph Pantginis has reiterated a Buy rating on Pharming (NASDAQ: PHAR) and maintained a price target of $37 for the stock. This endorsement reflects confidence in the company&#39;s performance and potential in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/CCL:1790093754008</loc>
    <lastmod>2026-09-22T16:15:54.008Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/22/New-York--Usa---17-February-2021-Carniva.jpg?width=250&amp;height=187</image:loc>
      <image:title>Why Is Carnival Stock Surging on Tuesday?</image:title>
      <image:caption>Carnival Corporation Ltd. (NYSE: CCL) stock surged 2.80% to $22.93 on Tuesday, driven by declining crude oil prices and a broader rally in the airline and travel sectors. The company is set to release its third-quarter earnings on September 29, with analysts expecting earnings of $1.35 per share on revenue of $8.4 billion. Recent analyst ratings from Goldman Sachs and Stifel maintained Buy ratings but lowered price forecasts to $30 and $35, respectively.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NVDA:1790093576080</loc>
    <lastmod>2026-09-22T16:12:56.080Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/22/AI-Chip-Smuggling-Cases.jpg?width=250&amp;height=187</image:loc>
      <image:title>EXCLUSIVE: Small AI Model Matches GPT-4.1 at Forecasting as Olas Founding Member Says Frontier Models Face ‘Increasing Economic Pressure’</image:title>
      <image:caption>Olas has introduced a new AI model, Olas-Predict-R1-14B, which achieved 75.8% accuracy in predicting real-world events, surpassing OpenAI&#39;s GPT-4.1 at 75.4%. The model was trained on over 214,000 forecasts from prediction markets, indicating a trend where specialized AI models are exerting economic pressure on larger general-purpose models. CEO David Minarsch noted that smaller models could change the economics of AI demand, particularly as major tech companies are projected to spend over $886.7 billion on AI infrastructure by 2026.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/CLDX:1790093499886</loc>
    <lastmod>2026-09-22T16:11:39.886Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CLDX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>HC Wainwright &amp;amp; Co. Maintains Buy on Celldex Therapeutics, Raises Price Target to $64</image:title>
      <image:caption>HC Wainwright &amp; Co. analyst Joseph Pantginis has maintained a Buy rating on Celldex Therapeutics (NASDAQ: CLDX) and increased the price target from $42 to $64.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/IONS:1790093467809</loc>
    <lastmod>2026-09-22T16:11:07.809Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/22/Muscular-Dystrophy.jpg?width=250&amp;height=187</image:loc>
      <image:title>Ionis to Seek Expedited FDA Review for ALS Drug</image:title>
      <image:caption>Ionis Pharmaceuticals Inc. (NASDAQ: IONS) and Otsuka announced positive topline results from their Phase 3 FUSION trial for ulefnersen, an investigational treatment for amyotrophic lateral sclerosis (ALS) caused by FUS gene mutations. The trial met its primary endpoint, showing significant improvements in functional impairment and survival compared to placebo. Otsuka plans to discuss expedited FDA review pathways for ulefnersen, which is the first treatment targeting the genetic cause of FUS-ALS. Ionis shares rose 0.88% to $45.29, near their 52-week low.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/BFLY:1790093407496</loc>
    <lastmod>2026-09-22T16:10:07.496Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/22/Stock-Market-Analysis-With-Candlestick-C.jpg?width=250&amp;height=187</image:loc>
      <image:title>Butterfly Network Stock Soars After Needham Initiates Buy</image:title>
      <image:caption>Butterfly Network Inc (NYSE: BFLY) shares surged 17.81% to $9.58 after Needham initiated coverage with a Buy rating and a 12-month price target of $10. The analyst highlighted the company&#39;s proprietary ultrasound technology and its Embedded segment, which includes partnerships worth an estimated $300 million by 2030. However, Needham cautioned about competition from larger firms and the need for ongoing investment in technology, as Butterfly has not yet reached profitability.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/LDOS:1790093315151</loc>
    <lastmod>2026-09-22T16:08:35.151Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/LDOS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Leidos Awarded $127M U.S. Army Contract To Continue Supplying Airborne Reconnaissance And Targeting Exploitation Multi-Mission Intelligence System</image:title>
      <image:caption>Leidos has been awarded a $127 million contract by the U.S. Army to continue supplying the Airborne Reconnaissance and Targeting Exploitation Multi-Mission Intelligence System. This contract extends Leidos&#39; support for the Artemis airborne ISR mission. The contract is part of the company&#39;s ongoing efforts to enhance military intelligence capabilities.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/TER:1790093065610</loc>
    <lastmod>2026-09-22T16:04:25.610Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TER/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>GS Microelectronics Collaborates With Teradyne To Construct Semiconductor Test, Evaluation Center</image:title>
      <image:caption>GS Microelectronics U.S., Inc. has entered into a multi-year strategic partnership with Teradyne, Inc. to create a semiconductor test and evaluation center aimed at enhancing customer time-to-market. This collaboration will combine GSME&#39;s design and manufacturing capabilities with Teradyne&#39;s automated test platforms, facilitating a high-performance environment for device evaluation and production readiness.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NTRA:1790092979437</loc>
    <lastmod>2026-09-22T16:02:59.437Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NTRA/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Natera shares are trading higher. The company announced that Japan&amp;#39;s pharma and medical devices agency has approved its Signatera test as a companion diagnostic in muscle-invasive bladder cancer.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/MAZE:1790092978184</loc>
    <lastmod>2026-09-22T16:02:58.184Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MAZE/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>BTIG Reiterates Buy on Maze Therapeutics, Maintains $46 Price Target</image:title>
      <image:caption>BTIG analyst Julian Harrison has reiterated a Buy rating on Maze Therapeutics (NASDAQ: MAZE) and has maintained a price target of $46 for the stock. This endorsement reflects confidence in the company&#39;s performance and potential in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/META:1790092851610</loc>
    <lastmod>2026-09-22T16:00:51.610Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/META/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>&amp;#34;Meta Is Testing A &amp;#39;Human Concierge&amp;#39; For Its New Personal Agent Muse&amp;#34; - Reuters Exclusive</image:title>
      <image:caption>Meta Platforms Inc. (META) is currently testing a &#39;human concierge&#39; feature for its AI assistant, Muse, which involves human contractors managing some phone calls made through the digital agent. This testing follows the recent public launch of Muse&#39;s phone calling feature. However, there are privacy concerns among employees regarding the potential for sensitive information to be inadvertently shared with call center contractors.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/VRTX:1790092517796</loc>
    <lastmod>2026-09-22T15:55:17.796Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/VRTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Vertex Pharmaceuticals shares are trading higher after the company announced results from a study of its inaxaplin candidate that showed a reduction in urine albumin to creatinine ratio at week 13 and was generally safe and well tolerated.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/SPCX:1790092214871</loc>
    <lastmod>2026-09-22T15:50:14.871Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/22/Ipo-Concept--Concept-Of-Accelerating-Gro.jpg?width=250&amp;height=187</image:loc>
      <image:title>SpaceX, OpenAI, Anthropic Are Making the IPO Market Look Small</image:title>
      <image:caption>SpaceX (NASDAQ: SPCX) has entered public markets with a valuation of approximately $2 trillion, while Anthropic and OpenAI are projected to reach valuations of $2 trillion and $1.2 trillion, respectively, potentially bringing their combined value to over $5 trillion. This figure surpasses the total value of 3,365 technology companies that went public from 1980 to 2025, which was $4.1 trillion at IPO. The trend indicates a shift in the IPO market, where AI companies are achieving significant valuations while still private, altering the landscape for public investors.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/AMD:1790091926692</loc>
    <lastmod>2026-09-22T15:45:26.692Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/22/Amd-Chairman-And-Ceo-Lisa-Su-Delivers-Th.jpg?width=250&amp;height=187</image:loc>
      <image:title>AMD Stock Beat Nvidia By 160 Points In 2026: A Historic AI Boom First</image:title>
      <image:caption>In 2026, Advanced Micro Devices Inc. (AMD) outperformed Nvidia Corp. (NVDA) by 165 percentage points, with AMD shares rising approximately 187% compared to Nvidia&#39;s 22% increase. This shift indicates a revaluation of AMD in the AI market, particularly as demand for CPUs grows alongside GPUs due to the rise of agentic AI workloads. Following this trend, AMD raised its 2030 server CPU market forecast from $60 billion to over $120 billion, anticipating significant growth driven by new AI applications.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/SPCX:1790091527614</loc>
    <lastmod>2026-09-22T15:38:47.614Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SPCX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>&amp;#39;SpaceXAI’s Grok Bot Agent Tops 400,000 Users After First Month&amp;#39; - Bloomberg</image:title>
      <image:caption>SpaceXAI&#39;s Grok Bot Agent has surpassed 400,000 users within its first month of launch. This rapid adoption indicates strong market interest and potential for growth in the AI sector. The company&#39;s stock, under the ticker SPCX, may experience impacts from this positive user engagement.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/BB:1790091251129</loc>
    <lastmod>2026-09-22T15:34:11.129Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/22/Blackberry.jpg?width=250&amp;height=187</image:loc>
      <image:title>What Is Going On With BlackBerry Stock Ahead Of Earnings?</image:title>
      <image:caption>BlackBerry Limited (NYSE: BB) shares rose by up to 8% in premarket trading following Coretura&#39;s selection of Alloy Kore, a software platform developed in partnership with BlackBerry&#39;s QNX, for its next-generation commercial vehicle platform. The company is set to report earnings on September 24, 2026, with an estimated EPS of 4 cents and revenue of $145.03 million, reflecting a year-over-year increase. RBC Capital maintains a Sector Perform rating with a price target of $9, while the stock was trading at $8.58, showing a 0.64% increase at the time of publication.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/CLDX:1790091197477</loc>
    <lastmod>2026-09-22T15:33:17.477Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CLDX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Cantor Fitzgerald Maintains Overweight on Celldex Therapeutics, Raises Price Target to $72</image:title>
      <image:caption>Cantor Fitzgerald analyst Kristen Kluska has maintained an Overweight rating on Celldex Therapeutics (NASDAQ: CLDX) and raised the price target from $61 to $72.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/BTCUSD:1790091039444</loc>
    <lastmod>2026-09-22T15:30:39.444Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/22/Tim-Draper-Headshot-v4.jpg?width=250&amp;height=187</image:loc>
      <image:title>Why Billionaire Tim Draper Calls Apple, Meta &amp;#39;Irresponsible&amp;#39; for Not Holding Bitcoin</image:title>
      <image:caption>Billionaire Tim Draper has urged major companies like Apple and Meta Platforms to hold Bitcoin on their balance sheets, citing risks from persistent government spending that could lead to inflation or banking system stress. He recommends businesses keep at least four weeks&#39; worth of Bitcoin as a hedge against financial risks. Draper also reiterated his long-standing target of $250,000 for Bitcoin, predicting broader retail adoption in about five years and envisioning a future where businesses conduct transactions entirely in Bitcoin.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ABVX:1790091001291</loc>
    <lastmod>2026-09-22T15:30:01.291Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ABVX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>BTIG Reiterates Buy on Abivax, Maintains $175 Price Target</image:title>
      <image:caption>BTIG analyst Julian Harrison has reiterated a Buy rating on Abivax (NASDAQ: ABVX) and maintained a price target of $175 for the stock. This endorsement suggests confidence in the company&#39;s future performance and potential growth.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NBIG:1790090973880</loc>
    <lastmod>2026-09-22T15:29:33.880Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/22/Konskie--Poland---May-03--2025-Nebius-Gr.jpg?width=250&amp;height=187</image:loc>
      <image:title>What Is Going on With Nebius Stock on Tuesday?</image:title>
      <image:caption>Nebius Group N.V. (NASDAQ: NBIS) stock rose approximately 5% on Tuesday, driven by reports of a planned 20% increase in GPU cloud prices starting October 1, reflecting strong demand in AI computing. The stock traded at $244.50, outperforming the broader technology sector, which saw a 0.2% gain. Notably, Nebius maintains a strong technical trend, trading 10.8% above its 20-day moving average and 50.2% above its 200-day average.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/TWLO:1790090785606</loc>
    <lastmod>2026-09-22T15:26:25.606Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TWLO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>TD Cowen Maintains Buy on Twilio, Raises Price Target to $300</image:title>
      <image:caption>TD Cowen analyst Derrick Wood has maintained a &#39;Buy&#39; rating on Twilio (NYSE: TWLO) and increased the price target from $260 to $300. This adjustment reflects a positive outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/BABA:1790090636459</loc>
    <lastmod>2026-09-22T15:23:56.459Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/22/Alibaba-Group-Global-Headquarters-At-Xix.jpg?width=250&amp;height=187</image:loc>
      <image:title>Alibaba Debuts AI Chip, Challenges Nvidia With Triple Processing Power</image:title>
      <image:caption>Alibaba Group Holding Limited (NYSE: BABA) introduced its new AI chip, the Zhenwu V900, which boasts three times the processing power of its current M890 chip and can scale to clusters of up to 500,000 chips, with production expected to start in Q1 2027. The company plans to invest $53 billion over three years to expand its global data center capacity to over 20 gigawatts by 2032, in response to rising AI demand. Following the announcement, Alibaba&#39;s stock rose 0.8% to $116.64.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/BNO:1790090245449</loc>
    <lastmod>2026-09-22T15:17:25.449Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BNO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Oil is trading lower after Iran reportedly offered to reopen the Strait of Hormuz within seven days if the U.S. would ease military pressure and lift its blockade of Iranian ports. Also, reports suggest that Saudi Arabia restarted East-West Pipeline operations and could resume exports from the Red Sea port of Yanbu.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/XNDU:1790090228856</loc>
    <lastmod>2026-09-22T15:17:08.856Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/22/Stock-Market-Chart-Showing-Falling-Equit.jpg?width=250&amp;height=187</image:loc>
      <image:title>Xanadu Stock Hits New Lows: What&amp;#39;s Happening?</image:title>
      <image:caption>Xanadu Quantum Technologies Ltd (NASDAQ: XNDU) shares fell 18.72% to $5.99, reaching a new low as the company&#39;s 180-day post-IPO lockup period expired, releasing approximately 255 million additional shares into the market. Prior to this, only about 43 million shares were tradable, leading to a significant increase in supply that outpaced buyer interest. The lockup period is designed to prevent early investors from selling shares immediately after an IPO, but its expiration often results in downward pressure on stock prices due to increased availability.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/SBET:1790090068427</loc>
    <lastmod>2026-09-22T15:14:28.427Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SBET/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>B. Riley Securities Maintains Buy on Sharplink, Raises Price Target to $14</image:title>
      <image:caption>B. Riley Securities analyst Fedor Shabalin has maintained a Buy rating on Sharplink (NASDAQ: SBET) and increased the price target from $12 to $14. This adjustment reflects a positive outlook for the company&#39;s performance in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NAKA:1790090015212</loc>
    <lastmod>2026-09-22T15:13:35.212Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NAKA/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>B. Riley Securities Maintains Buy on Nakamoto, Raises Price Target to $13</image:title>
      <image:caption>B. Riley Securities analyst Fedor Shabalin has maintained a Buy rating on Nakamoto (NASDAQ: NAKA) and increased the price target from $11 to $13.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/BDRX:1790090014918</loc>
    <lastmod>2026-09-22T15:13:34.918Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BDRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Watching Biodexa Pharmaceuticals; Zacks Small-Cap Research Gives Stock $9 Price Valuation</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/MSTR:1790089961049</loc>
    <lastmod>2026-09-22T15:12:41.049Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MSTR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>B. Riley Securities Maintains Buy on Strategy, Raises Price Target to $195</image:title>
      <image:caption>B. Riley Securities analyst Fedor Shabalin has maintained a Buy rating on Strategy (NASDAQ:MSTR) and raised the price target from $175 to $195. This adjustment reflects a positive outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/HSDT:1790089864933</loc>
    <lastmod>2026-09-22T15:11:04.933Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HSDT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>B. Riley Securities Maintains Buy on Solana, Raises Price Target to $4</image:title>
      <image:caption>B. Riley Securities analyst Fedor Shabalin has maintained a &#39;Buy&#39; rating on Solana (NASDAQ: HSDT) and increased the price target from $3.5 to $4. This adjustment reflects a positive outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/FWDI:1790089758840</loc>
    <lastmod>2026-09-22T15:09:18.840Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/FWDI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>B. Riley Securities Maintains Buy on Forward Industries, Raises Price Target to $11</image:title>
      <image:caption>B. Riley Securities analyst Fedor Shabalin has maintained a Buy rating on Forward Industries (NASDAQ: FWDI) and raised the price target from $9 to $11. This adjustment reflects a positive outlook for the company in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/DAVA:1790089696363</loc>
    <lastmod>2026-09-22T15:08:16.363Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/DAVA/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Endava shares are trading lower after Willaim Blair downgraded the stock from Market Perform to Underperform. Also Deutsche Bank lowered its price target on the stock from $3 to $2.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/BMNR:1790089677777</loc>
    <lastmod>2026-09-22T15:07:57.777Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BMNR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>B. Riley Securities Maintains Buy on BitMine Immersion, Raises Price Target to $34</image:title>
      <image:caption>B. Riley Securities analyst Fedor Shabalin has maintained a Buy rating on BitMine Immersion (NYSE: BMNR) and increased the price target from $30 to $34. This adjustment reflects a positive outlook for the company&#39;s stock performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ASST:1790089621493</loc>
    <lastmod>2026-09-22T15:07:01.493Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ASST/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>B. Riley Securities Maintains Buy on Strive, Raises Price Target to $33</image:title>
      <image:caption>B. Riley Securities analyst Fedor Shabalin has maintained a &#39;Buy&#39; rating on Strive (NASDAQ: ASST) and increased the price target from $26 to $33. This adjustment reflects a positive outlook for the company&#39;s stock performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/DOCN:1790089274583</loc>
    <lastmod>2026-09-22T15:01:14.583Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/DOCN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>DigitalOcean Announces Public Preview Of Managed Agents Service For Running AI Agents</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/LLY:1790089250431</loc>
    <lastmod>2026-09-22T15:00:50.431Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/LLY/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>TD Cowen Reiterates Buy on Eli Lilly, Maintains $1250 Price Target</image:title>
      <image:caption>TD Cowen analyst Steve Scala has reiterated a Buy rating on Eli Lilly (NYSE: LLY) and maintained a price target of $1250 for the stock. This endorsement reflects confidence in the company&#39;s performance and market position.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/GRML:1790089044794</loc>
    <lastmod>2026-09-22T14:57:24.794Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/GRML/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Greenland Mines Shares Halted On Circuit Breaker To The Downside, Stock Now Up 68.47%</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/UNP:1790088964827</loc>
    <lastmod>2026-09-22T14:56:04.827Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/UNP/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Union Pacific Corp Says Surface Transportation Board Unanimously Rejects Opponents’ Requests To Dismiss Merger Application Without Review</image:title>
      <image:caption>Union Pacific Corporation (NYSE: UNP) and Norfolk Southern Corporation (NYSE: NSC) received a significant boost as the Surface Transportation Board (STB) unanimously rejected requests from merger opponents to dismiss their merger application. This decision allows the STB to proceed with its review of the merger, which aims to create America&#39;s first transcontinental railroad, enhancing freight transportation efficiency and reducing truck traffic on highways. Additionally, the SMART-MD union has established a jobs-for-life agreement with the railroads, indicating strong union support for the merger.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/GRML:1790088923640</loc>
    <lastmod>2026-09-22T14:55:23.640Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/GRML/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Greenland Mines Shares Halted On Circuit Breaker To The Upside, Stock Now Up 82.38%</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/GOAI:1790088886941</loc>
    <lastmod>2026-09-22T14:54:46.941Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/GOAI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Eva Live Form4 Filing Shows CEO David Boulette Acquires Over 4.2M Shares Via Option Exercise And Salary Compensation</image:title>
      <image:caption>CEO David Boulette of Eva Live has acquired over 4.2 million shares of the company through the exercise of stock options and salary compensation, as disclosed in a recent SEC filing. This acquisition is significant for the company&#39;s stock performance and reflects Boulette&#39;s commitment to the company&#39;s future. The stock ticker for Eva Live is GOAI.</image:caption>
    </image:image>
  </url>
</urlset>